DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Funds an early, hypothesis-driven ALS drug or therapy idea before there's data proving it will work.
About
Most ALS therapeutic ideas die for a boring reason: nobody will fund the very first, riskiest test of whether they're worth pursuing at all. This award exists for exactly that gap.
What's funded is early, hypothesis-driven drug or therapy discovery work, aimed at generating the preliminary data that opens up a future line of therapeutic investigation — not a therapy that's already validated.
The…
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.